CLX Investment Company Announces Posting of Pictures from Zonda Inc.'s Appearance at MEDICA Medical Trade Event; Successful Exhibit Results in over 200 Potential Worldwide Distribution Partners.

TEMECULA, Calif. -- CLX Investment Company, Inc. (OTCBB:CLXN) today announced that CLX has posted several photographs from portfolio investment Zonda, Inc.'s successful appearance at MEDICA, the world's largest medical trade fair, on its website at http://www.clxinvestments.com/zonda.asp.

Zonda's exhibit at MEDICA, which was held November 16-19 in Dusseldorf, Germany, attracted the attention of distributors from virtually every country in Europe and Asia. Heading the delegation at MEDICA was Patrick L. Edgerton, vice president of European/United States operations for Zonda, Inc., whose central focus at the event was to make contact with the strongest possible distribution partners for Zonda in markets around the world.

"Zonda has reported that the response from its exhibit at MEDICA has been tremendous, with over 200 preliminary contacts from distribution candidates made during the event itself, and they are already fielding requests for master distribution contracts from those who visited the booth and are interested in carrying Zonda's products," commented Tammy D. Dunn, chief executive officer of CLX Investment Company. "Channels have been established for Zonda to work directly with effective distribution partners, including some of the largest such companies in European and Asian markets."

Zonda Inc., a privately-held company that specializes in test products that serve the medical diagnostic (IVD), food safety and sanitation testing markets, is expanding the distribution of its product lines into broader markets around the world, beginning with a focus in Europe. The first product targeted for accelerated marketing and distribution efforts is an innovative, rapid, self-contained diagnostic device for the detection of Chlamydia, which carries a CE mark for professional and over-the-counter use. The device, which is marketed under the HandiLab-C name, is superior to its competition due to its comparable accuracy (compared directly to PCR testing), ease of use, compact design, long shelf life, rapid results and cost effectiveness.

During Zonda's visit to Europe, the company hosted a dinner for potential distribution companies in Vienna, Austria, and over 30 countries were represented at the event, including the United States, United Kingdom, Belgium, France, Russia, Holland, Romania and Vietnam.

"Not only is Zonda focusing on strengthening its distribution relationships in worldwide markets, but the company is also pursuing the expansion of manufacturing capacity for Zonda's product line. One method Zonda is pursuing is the establishment of manufacturing in China. This would increase its overall manufacturing capabilities to meet the growing demand for its products and potentially lower manufacturing costs, as well as facilitating expedited delivery to Asian markets," continued Ms. Dunn.

"MEDICA and the related events exceeded our expectations, and we anticipate that a number of the contacts its management made during the fair will develop into strong business relationships that lead directly to increased revenues for Zonda," added Ms. Dunn.

To sign up to receive information by email directly from CLX Investment Company when new press releases, investor newsletters, SEC filings or other information is disclosed, please visit http://www.clxinvestments.com/email.asp.

About the Company

CLX Investment Company (www.clxinvestments.com) has elected to be regulated as a Business Development Company pursuant to Section 54 of the Investment Company Act of 1940, and is pursuing a business plan wherein the Company seeks to make investment in developing companies with the goal of providing return for its shareholders.

CLX has acquired a 49% interest in eStrategy Solutions, Inc. (www.clxinvestments.com/estrategysolutions), a Texas-based e-learning provider that has developed online training solutions for government entities and other professional organizations. The Company has made an investment in ActionView International, Inc. (www.actionviewinternational.com), a publicly-traded global manufacturer and marketer of "smart" scrolling advertising billboards. CLX holds a 20% equity interest in Zonda, Inc. (www.zondainc.com), a privately-held company that specializes in test products that serve the medical diagnostic, bacterial food testing and environmental surfaces testing markets.

All statements included in this release, including statements regarding potential future plans and objectives of CLX Investments, are forward-looking statements. Such statements are necessarily subject to risks and uncertainties, some of which are significant in scope and nature beyond CLX Investments' control. There can be no assurance that such statements will prove accurate. Actual results and future events could differ materially from those anticipated in such statements depending on many factors. Historical results are not necessarily indicative of future performance.